About 200 reports

  • Dementia
  • DEMENTIA

You can easily book an appointment with one online.

  • Dementia
  • Allergan plc
  • Eisai Co., Ltd.
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd.

Dementia Associated with Alzimer’s Disease Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018-2026 ##.

  • Dementia
  • Mental Health
  • Pathology
  • Company Financials
  • Forecast
  • UK Dementia Cost, By Type of
  • Australia Dementia Market Outlook

One in six people over ## have dementia.

  • Dementia
  • Axovant Sciences Ltd.
  • Biotie Therapies Corp.
  • Novartis AG
  • Pfizer Inc.
  • SUB-TYPE OF CO-MORBID DEMENTIA, TOTAL (000S)
  • USA PREVALENCE OF LEWY BODY DEMENTIA BY 5-YR AGE COHORT, FEMALES (000S)

Lewy body dementias.

  • Dementia
  • United States
  • Forecast
  • FEATURES OF VASCULAR DEMENTIA PATIENTS
  • Prevalence of Vascular Dementia, total (000s)

Prevalence of Vascular Dementia, males (##s) Table ##.

  • Dementia
  • Mental Health
  • Pathology
  • East Asia
  • Eating Problems
  • 4.3 SYMPTOMS

Dementia Due to a lack of a curative treatment, the use of symptomatic therapies and maintaining a high quality of life is one the main goals of treatment.

  • Dementia
  • Therapy
  • United States
  • Forecast
  • Ionis Pharmaceuticals, Inc.
  • 4. NORTH AMERICA NURSE CALL SYSTEMS- MARKET LANDSCAPE

TABLE ##.

  • Dementia
  • World
  • Forecast
  • Market Size
  • Ascom Holding AG
  • Alzheimer's disease in 2016, and the patients diagnosed with Alzheimer's or another dementia
  • Alzheimer's and other dementias, including blood vessel damage and genetic risk

© IGATE RESEARCH PAGE ## OF ## Global Alzheimer' s Disease Drugs Market - Overview Alzheimer' s disease is the most common cause of dementia among older people.

  • Dementia
  • World
  • Biogen Idec Inc.
  • Eisai Co., Ltd.
  • Roche Group

Cognition and Memory Enhancement Drugs: Technologies and Global Markets Chapter ## Introduction Study Goals and Objectives Reasons for Doing This Study Scope of Report Information Sources and Methodology Intended Audience Geographic Breakdown Analyst’s Credentials Related BCC Research Report

  • Dementia
  • Mental Health
  • World
  • DSM-IV Criteria for the Diagnosis of Dementia
  • 4.1 BIBLIOGRAPHY

Alzheimer' s and Dementia; ##(##): ##-##.

  • Dementia
  • Spain
  • United States
  • World
  • Forecast

GLOBAL ALZHEIMER’S DISEASE THERAPEUTICS AND DIAGNOSTICS MARKET FORECAST 2018-2026 ##.

  • Dementia
  • Therapy
  • World
  • Key Clinical Trial Landscape Updates
  • KEY EVENTS AFFECTING THE AD COMPETITIVE LANDSCAPE (JUNE 2018-JULY 2018)

The latest data on Eisai' s AD/ dementia pipeline was presented at AAIC 2018.

  • Dementia
  • United States
  • Eisai Co., Ltd.
  • Novartis AG
  • Roche Group
  • EXELON
  • EISAI PHARMACEUTICALS

You can easily book an appointment with one online.

  • Dementia
  • Forecast
  • Allergan plc
  • Eisai Co., Ltd.
  • Novartis AG
  • 6.1.1 PROBABLE AD DEMENTIA
  • DSM-IV CRITERIA FOR THE DIAGNOSIS OF DEMENTIA

ALZHEIMER' S & DEMENTIA; ##(##): ##-##.

  • Dementia
  • Allergan plc
  • Biogen Idec Inc.
  • Eisai Co., Ltd.
  • Novartis AG
  • Nov 16, 2017: Researchers identify first brain training exercise positively linked to dementia prevention
  • Nov 26, 2018: Researcher gets $3.37 million grant to improve quality of life for people with dementia

Therapy Area Central Nervous System Dermatology Gastrointestinal Genetic Disorders Hematological Disorders Immunology Musculoskeletal Oncology Other Diseases No. of Deals ## ## ## ## ## ## ## ## ## Deal Value (US$ million) NA NA NA NA NA

  • Dementia
  • Healthcare
  • Pharmaceutical
  • Salicylic Acid
  • United States
  • May 21, 2018: Our scientists receive £150,000 boost for pioneering dementia research
  • May 21, 2018: Sheffield scientists get £150K boost for pioneering dementia research

" Many people who have a loved one with dementia notice that symptoms get worse following an infection or injury to the body, and we want to know exactly why this happens.

  • Dementia
  • Healthcare
  • Pharmaceutical
  • Therapy
  • United Kingdom

Global Alzheimer’s Disease Therapeutics and Diagnostics Market 2018-2028 ##.

  • Dementia
  • Diagnostics
  • Mental Health
  • World
  • Market Size
  • JAN 09, 2018: LARGE-SCALE PROTEIN ANALYSIS CAN PROVIDE NEW POSSIBILITIES FOR DIAGNOSIS AND TREATMENT IN DEMENTIA
  • OCT 24, 2017: BLOOD-THINNING DRUGS APPEAR TO PROTECT AGAINST DEMENTIA AS WELL AS STROKE IN AF PATIENTS

Many change drugs JAN ##, 2018: LARGE-SCALE PROTEIN ANALYSIS CAN PROVIDE NEW POSSIBILITIES FOR DIAGNOSIS AND TREATMENT IN DEMENTIA One of the most fascinating features of the brain is how it undergoes synaptic plasticity that is the basis of learning and memory, abilities that grea

  • Cancer
  • Dementia
  • Sweden
  • Karolinska Institutet Holding
  • Takeda Pharmaceutical Company Limited

According to Alzheimer’s Association, one in every ## adults in the United States dies with Alzheimer’s or another dementia.

  • Dementia
  • Mental Health
  • Therapy
  • North America
  • Market Size

EUROPE ALZHEIMER’S DISEASE THERAPEUTICS AND DIAGNOSTICS MARKET FORECAST 2018-2026 ##.

  • Dementia
  • Mental Health
  • Therapy
  • Europe
  • Market Size
  • DISEASE OVERVIEW

AD is a subtype of dementia, and accounts for approximately ##% of the total dementia cases worldwide.

  • Dementia
  • Allergan plc
  • Eisai Co., Ltd.
  • Novartis AG
  • Roche Group
  • Nicergoline Major Producer and Their Market Share
  • Rivastigmine

In mixed dementia, Alzheimer' s and vascular dementia occur together.

  • Dementia
  • China
  • Trade
  • Janssen Biotech, Inc.
  • Xian-Janssen Pharmaceutical Ltd.

ASIA PACIFIC ALZHEIMER’S DISEASE THERAPEUTICS AND DIAGNOSTICS MARKET FORECAST 2018-2026 ##.

  • Dementia
  • Therapy
  • APAC
  • Market Size
  • Nicergoline Major Producer and Their Market Share
  • Overview

In mixed dementia, Alzheimer' s and vascular dementia occur together.

  • Dementia
  • China
  • Demand
  • Guizhou Yibai Pharmaceutical Co., Ltd.
  • Kunming Longjin Pharmaceutical Co Ltd
  • NEURODEGENERATIVE DISORDERS THERAPEUTICS MARKET, COMORBIDITIES ASSOCIATED WITH
  • 2.1.5 MULTIPLE SCLEROSIS

Alzheimer' s & Dementia; ##(##): ##-## Inglese M (2006).

  • Dementia
  • Biogen Idec Inc.
  • Novartis AG
  • Roche Group
  • Sanofi S.A.
  • MARKET DRIVERS

AD is one of the most common types of NDDs.

  • Dementia
  • Eli Lilly & Co.
  • F. Hoffmann-La Roche Ltd.
  • Johnson & Johnson
  • Merck & Co., Inc.
  • 1.1 Definition of Dementia
  • 1.1.2 Types of Dementia

Figure ##. ##: Dementia Cost in the UK by Categories (2014E) Source: Dementia UK, Koncept Analytics Unpaid Care Social Care Health Care Other Costs ##% ##% ##% ##% ##.

  • Dementia
  • Eli Lilly & Co.
  • Novartis AG
  • Pfizer Inc.
  • Roche Group
  • AIDS ASSOCIATED DEMENTIA THERAPEUTICS, GLOBAL, CLINICAL TRIALS BY TRIAL STATUS, 2018*
  • AIDS ASSOCIATED DEMENTIA THERAPEUTICS, GLOBAL, CLINICAL TRIALS BY REGION (%), 2018*

CLINICAL TRIALS BY PHASE IN E## COUNTRIES AIDS ASSOCIATED DEMENTIA THERAPEUTICS, E## COUNTRIES, CLINICAL TRIALS BY PHASE, 2018* AIDS ASSOCIATED DEMENTIA THERAPEUTICS, E## COUNTRIES, CLINICAL TRIALS BY PHASE, 2018* AIDS ASSOCIATED DEMENTIA THERAPEUTICS, E## COUNTRIES, CLINICAL

  • Dementia
  • Medical Biotechnology
  • Therapy
  • World
  • Product Initiative
  • TOP COMPANIES PARTICIPATING IN VASCULAR DEMENTIAS THERAPEUTICS CLINICAL TRIALS
  • CLINICAL TRIALS BY G7 COUNTRIES: PROPORTION OF VASCULAR DEMENTIAS TO CENTRAL NERVOUS SYSTEM CLINICAL TRIALS

VASCULAR DEMENTIAS THERAPEUTICS CLINICAL TRIALS, GLOBAL, ONGOING CLINICAL TRIALS BY PROMINENT DRUGS, 2018* PROMINENT DRUGS VASCULAR DEMENTIAS THERAPEUTICS CLINICAL TRIALS, GLOBAL, ONGOING CLINICAL TRIALS BY PROMINENT DRUGS, 2018* VASCULAR DEMENTIAS THERAPEUTICS CLINICAL TR

  • Clinical Trial
  • Dementia
  • Pharmaceutical
  • World
  • Product Initiative
  • 10.1.4 Types of Dementia
  • Untitled

Drivers and their Impact Impact on Key Customer Segments Driver Unmet Medical Needs Increase in Patient Population Low Low ## ## ## ## ## High High Hospitals ## ## ## ## ## Promising Drug Pipeline Special Provision for Rare Diseases Low Low ## ## ## ## ## High High ## ## ## ## ##

  • Dementia
  • Biogen Idec Inc.
  • Merck Serono S.A.
  • Novartis AG
  • Pfizer Inc.